Scientists create library of mutant bacteria to study antibiotic resistance

A third of patients with relapsed/refractory multiple myeloma responded to pembrolizumab (Keytruda) plus single-fraction radiotherapy (RT), a small clinical study showed. Results at 3 months

Man­u­fac­tur­er Nat­co Phar­ma was hit with a warn­ing let­ter ear­li­er this month over vi­o­la­tions at its fa­cil­i­ty in the In­di­an state of Telan­gana, fol­low­ing an

Rare neu­ro­log­i­cal dis­ease drug de­vel­op­er Har­mo­ny Bio­sciences ac­quired Epy­genix Ther­a­peu­tics and its pipeline of treat­ments for rare epilep­sy con­di­tions. Har­mo­ny paid $35 mil­lion up­front, and